Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2011; 17(2): 219-225
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.219
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.219
Patients (n = 41) | |
Age (yr) | |
mean ± SD | 47 ± 14 |
Range | 20-77 |
Sex | |
Male | 17 (41.5) |
Female | 24 (58.5) |
Tumor type | |
Carcinoid | 12 (29.3) |
Functional PNET | 19 (46.3) |
Non-functional PNET | 10 (24.4) |
Tumor grade | |
Well-differentiated NET | 13 (31.7) |
Well-differentiated NEC | 26 (63.4) |
Poorly differentiated NEC | 1 (2.4) |
Unknown | 1 (2.4) |
Metastases | |
Present | 26 (63.4) |
Lymph node only | 9 (34.6) |
Liver only | 7 (26.9) |
Both | 10 (38.5) |
Absent | 15 (36.6) |
Tumors (n = 60) | |
Primary or metastatic tissues | |
Primary | 45 (75.0) |
Metastasis | 15 (25.0) |
Angio-invasion | |
Present | 11 (18.3) |
Absent | 49 (81.7) |
Tumor size (mean ± SD, cm) | |
Carcinoids | 3.4 ± 2.7 |
Functional PNETs | 1.9 ± 1.7 |
Non-functional PNETs | 3.6 ± 2.4 |
- Citation: Kuiper P, Hawinkels LJ, Jonge-Muller ES, Biemond I, Lamers CB, Verspaget HW. Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2011; 17(2): 219-225
- URL: https://www.wjgnet.com/1007-9327/full/v17/i2/219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i2.219